S E Regnell1, P Peterson2, L Trinh2, P Broberg3, P Leander4, Å Lernmark5, S Månsson2, H Elding Larsson5. 1. Pediatric Endocrinology, Diabetes and Celiac Disease Unit, Lund University/Clinical Research Centre and Skåne University Hospital, Malmö. simon.regnell@med.lu.se. 2. Medical Radiation Physics, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö 3. Department of Cancer Epidemiology, Department of Clinical Sciences, Lund University and Skåne University Hospital, Lund. 4. Department of Radiology, Department of Translational Medicine, Lund University and Skåne University Hospital, Malmö, Sweden. 5. Pediatric Endocrinology, Diabetes and Celiac Disease Unit, Lund University/Clinical Research Centre and Skåne University Hospital, Malmö
Abstract
AIMS: People with Type 1 diabetes have smaller pancreases than healthy individuals. Several diseases causing pancreatic atrophy are associated with pancreatic steatosis, but pancreatic fat in Type 1 diabetes has not been measured. This cross-sectional study aimed to compare pancreas size and fat fraction in children with Type 1 diabetes and controls. METHODS: The volume and fat fraction of the pancreases of 22 children with Type 1 diabetes and 29 controls were determined using magnetic resonance imaging. RESULTS: Pancreas volume was 27% smaller in children with diabetes (median 34.9 cm(3) ) than in controls (47.8 cm(3) ; P < 0.001). Pancreas volume correlated positively with age in controls (P = 0.033), but not in children with diabetes (P = 0.649). Pancreas volume did not correlate with diabetes duration, but it did correlate positively with units of insulin/kg body weight/day (P = 0.048). A linear model of pancreas volume as influenced by age, body surface area and insulin units/kg body weight/day found that insulin dosage correlated with pancreas volume after controlling for both age and body surface area (P = 0.009). Pancreatic fat fraction was not significantly different between the two groups (1.34% vs. 1.57%; P = 0.891). CONCLUSIONS: Our findings do not indicate that pancreatic atrophy in Type 1 diabetes is associated with an increased pancreatic fat fraction, unlike some other diseases featuring reduced pancreatic volume. We speculate that our results may support the hypotheses that much of pancreatic atrophy in Type 1 diabetes occurs before the clinical onset of the disease and that exogenous insulin administration decelerates pancreatic atrophy after diabetes onset.
AIMS: People with Type 1 diabetes have smaller pancreases than healthy individuals. Several diseases causing pancreatic atrophy are associated with pancreatic steatosis, but pancreatic fat in Type 1 diabetes has not been measured. This cross-sectional study aimed to compare pancreas size and fat fraction in children with Type 1 diabetes and controls. METHODS: The volume and fat fraction of the pancreases of 22 children with Type 1 diabetes and 29 controls were determined using magnetic resonance imaging. RESULTS:Pancreas volume was 27% smaller in children with diabetes (median 34.9 cm(3) ) than in controls (47.8 cm(3) ; P < 0.001). Pancreas volume correlated positively with age in controls (P = 0.033), but not in children with diabetes (P = 0.649). Pancreas volume did not correlate with diabetes duration, but it did correlate positively with units of insulin/kg body weight/day (P = 0.048). A linear model of pancreas volume as influenced by age, body surface area and insulin units/kg body weight/day found that insulin dosage correlated with pancreas volume after controlling for both age and body surface area (P = 0.009). Pancreatic fat fraction was not significantly different between the two groups (1.34% vs. 1.57%; P = 0.891). CONCLUSIONS: Our findings do not indicate that pancreatic atrophy in Type 1 diabetes is associated with an increased pancreatic fat fraction, unlike some other diseases featuring reduced pancreatic volume. We speculate that our results may support the hypotheses that much of pancreatic atrophy in Type 1 diabetes occurs before the clinical onset of the disease and that exogenous insulin administration decelerates pancreatic atrophy after diabetes onset.
Authors: Martha L Campbell-Thompson; Stephanie L Filipp; Joseph R Grajo; Bimota Nambam; Richard Beegle; Erik H Middlebrooks; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Michael J Haller Journal: Diabetes Care Date: 2018-12-14 Impact factor: 19.112
Authors: Brendan M McCleary; Andrew T Trout; Lin Fei; Qin Sun; Suraj D Serai; Jonathan R Dillman; Maisam Abu-El-Haija Journal: Pediatr Radiol Date: 2020-02-11
Authors: Melena D Bellin; Mark Lowe; M Bridget Zimmerman; Michael Wilschanski; Steven Werlin; David M Troendle; Uzma Shah; Sarah J Schwarzenberg; John F Pohl; Emily Perito; Chee Yee Ooi; Jaimie D Nathan; Veronique D Morinville; Brian A McFerron; Maria R Mascarenhas; Asim Maqbool; Quin Liu; Tom K Lin; Sohail Z Husain; Ryan Himes; Melvin B Heyman; Tanja Gonska; Matthew J Giefer; Cheryl E Gariepy; Steven D Freedman; Douglas S Fishman; Bradley Barth; Maisam Abu-El-Haija; Aliye Uc Journal: J Pediatr Gastroenterol Nutr Date: 2019-11 Impact factor: 2.839
Authors: John Virostko; Jon Williams; Melissa Hilmes; Chris Bowman; Jordan J Wright; Liping Du; Hakmook Kang; William E Russell; Alvin C Powers; Daniel J Moore Journal: Diabetes Care Date: 2018-12-14 Impact factor: 19.112
Authors: Timothy P Foster; Brittany Bruggeman; Martha Campbell-Thompson; Mark A Atkinson; Michael J Haller; Desmond A Schatz Journal: Endocr Pract Date: 2020-12 Impact factor: 3.443
Authors: Nayara C Leite; Elad Sintov; Torsten B Meissner; Michael A Brehm; Dale L Greiner; David M Harlan; Douglas A Melton Journal: Cell Rep Date: 2020-07-14 Impact factor: 9.995